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New technology has enriched the diagnostic armament-
arium of dermatologists and led to a major shift in the
examination of pigmented lesions (Marghoob et al, 2003).
Digital skin imaging and whole-body photography, for ex-
ample, allow for easy image capture, storage, and retrieval,
all of which facilitates detection of a new or changed lesion.
Dermoscopy reveals novel features under the skin surface
previously not visible to the naked eye and thereby en-
hances the number of diagnostically useful parameters
(Marghoob et al, 2003). Among non-invasive imaging tech-
niques, confocal scanning laser microscopy (CSLM) stands
out because of its high resolution (Gonzalez et al, 2003). It
can visualize in vivo microanatomic structures, such as the
epidermis, and individual cells, including melanocytes,
thereby allowing a ‘‘quasi-histologic’’ (Busam et al,
2001a, b) skin examination at the bedside. The term ‘‘qua-
si-histologic’’ refers to the fact that although cells and tissue
architecture can be examined using CSLM, the level of detail
is still significantly inferior to conventional light microscopy.
A currently available commercial reflectance-CSLM de-
livers ‘‘optical sections’’ within the superficial layers of the
skin (Rajadhyaksha et al, 1995, 1999). Outlines of cells and
their architecture are imaged in en face sections (oriented
parallel to the skin surface) with a measured lateral reso-
lution of 0.7 mm and an axial resolution (i.e., optical section
thickness) of 3 mm, to a maximum depth of 100–200 mm
(depth of the papillary dermis and superficial reticular de-
rmis) (Rajadhyaksha et al, 1995, 1999). Back-scattering of
the incident laser light because of variations in the refractive
indices of cell organelles provides contrast in the confocal
image (Rajadhyaksha et al, 2004). At a wavelength of 830
nm, melanosomes and melanin pigment produce strong
back-scatter, which renders the cytoplasm of melanocytes
and pigmented keratinocytes bright in reflectance confocal
images (Rajadhyaksha et al, 1995, 1999, 2004).
Given the high resolution of CSLM, there has been hope
that established criteria from conventional light microscopy
can be applied for the interpretation of confocal images of
pigmented lesions. For this to be feasible, it is necessary to
recognize melanocytes in confocal images and to distin-
guish them from other pigmented cells, such as melanoph-
ages or pigmented keratinocytes. This is indeed possible
(Busam et al, 2001a, b). Furthermore, several investigators
have already documented that melanoma can be diag-
nosed using CSLM (Busam et al, 2001a, b, 2002; Langley
et al, 2001; Gerger et al, 2004; Pellacani et al, 2004). But, the
number of examined cases has been small, which is why
there is insufficient knowledge about the sensitivity and
specificity of various criteria applicable for diagnosing me-
lanoma on confocal images. The article in this issue of the
Journal of Investigative Dermatology by Pellacani et al from
the Departments of Dermatology and Pathology of the Uni-
versity of Modena and Reggio Emila, represents an impor-
tant contribution to the field by examining the association
of various proposed criteria for the diagnosis of melanoma
by CSLM on a larger number of pigmented lesions (2005).
They examined 56 melanocytic nevi and 28 melanomas by
CSLM and conventional histology.
Since prominent pagetoid spread of melanocytes is a
histologic feature strongly associated with in situ melanoma,
we had previously emphasized the potential importance of
this parameter for the diagnosis of melanoma on confocal
images (Busam et al, 2002). Other investigators had sug-
gested a different set of criteria, placing more emphasis on
the presence or absence of an abnormal epidermal back-
ground architecture (epidermal ‘‘disarray’’) and bright gran-
ular particles (Langley et al, 2001). The weakness of the latter
set of parameters was that it lacked a direct histologic cor-
relate that was known to be of high value for the diagnosis of
melanoma. Disturbance of epidermal architecture, for exam-
ple, is not specific for melanoma, but can be seen in trau-
matized nevi as well as in non-melanocytic lesions, such as
irritated keratoses. Furthermore, not all melanomas are as-
sociated with significant alterations of the epidermis, such as
the loss of the keratinocytic honeycomb pattern.
In this issue of the Journal of Investigative Dermatology,
Pellacani et al confirm the diagnostic value of pagetoid
melanocytosis for the diagnosis of melanoma using CSLM.
Pagetoid melanocytosis proved to be the most robust fea-
ture associated with melanoma with an excellent correlation
between CSLM and histology. Epidermal disarrangement
was found to be less reliable. It was neither specific (it was
also seen in a Spitz’s nevus) nor sensitive (it was seen only
30% of melanomas), in spite of the fact that nodular
melanomas were excluded by the study design. While
the apparent common detection of pagetoid melanocytosis
in the majority of melanomas (after exclusion of nodular
melanomas) supports the utility of this parameter in the ex-
amination of pigmented lesions by CSLM, the authors right-
fully point out a potential pitfall. Pagetoid melanocytosis can
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also be seen in benign nevi, such as acral nevi, congenital
nevi, Spitz’s nevi, traumatized, or recurrent nevi. Thus, the
diagnostic significance of this feature is—similar to con-
ventional histologic analysis—context-dependent, and cor-
relation with other histologic features and the clinical
presentation is critical for a correct diagnosis. It also should
be noted that CSLM may sometimes not reveal pagetoid
melanocytes when, in fact, melanoma is present (false neg-
ative confocal result), as highlighted in Fig 1.
Another important potential pitfall in the assessment of
confocal images mentioned by the authors is the nature of
bright dendritic cells. While during the examination of a clin-
ically pigmented lesion by CSLM the detection of bright
dendritic cells in the spinous cell layer raises concern about
melanoma, not all dendritic cells need to be melanocytes.
The authors speculate whether some intraepidermal dendri-
tic cells in confocal images may represent Langerhans cells.
In our own experience this is indeed the case. Especially
inflamed nevi, such as a nevus with associated eczematous
features, may show an increased number of intraepidermal
Langerhans cells simulating pagetoid melanocytosis by
CSLM and possibly leading to an erroneous suspicion for
melanoma (Fig 2).
Such pitfalls should not discourage the use of CSLM. To
the contrary, they simply reflect the fact that knowledge
about the potential diagnostic value and limitations of this
image technology is evolving and merits additional studies.
Furthermore, pitfalls exist in conventional histology too. Pa-
thologists not infrequently struggle with conflicting or non-
specific histologic features and need to weigh them against
each other and correlate the histologic data with the clinical
presentation.
One issue that would be of interest to the reader to better
judge the clinical use of CSLM is to know in how many
cases the use of CSLM actually made a difference in the
diagnosis and management of a pigmented lesion. The au-
thors did not present any clinical pictures or data to indicate
whether there were cases in which the detection of pagetoid
melanocytosis by CSLM was instrumental for the ‘‘bedside’’
diagnosis of melanoma, or whether most of the lesions were
already fairly obvious melanomas or highly suspicious by
conventional clinical criteria and/or dermoscopic features.
Figure 1
Melanoma that was not recognized
clinically or on confocal images.
(A) Confocal image of a facial lesion
thought to be clinically ‘‘negative’’ for me-
lanoma shows a preserved honeycomb
pattern of epidermal keratinocytes. (B)
The corresponding histology reveals in
situ melanoma.
Figure 2
Langerhans cells may simulate melan-
ocytes on confocal images. (A) Confo-
cal image of a bright dendritic cells within
the spinous cell layer of the epidermis. (B)
Conventional histology reveals a com-
pound melanocytic nevus. (C) No page-
toid melanocytosis is seen on an
immunostain for Melan-A. (D) Numerous
Langerhans cells (dendritic cells immuno-
positive for CD1a) are present.
viii BUSAM ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
The cumulative experience with CSLM by different in-
vestigators clearly holds promise for this technology in the
future practice of dermatology. Although it is currently too
expensive and laborious to be considered as a screening
tool for melanoma, with minor advances CSLM may be-
come practical for assessing pigmented lesions that have
been selected as suspicious on the basis of clinical exam-
ination and/or dermoscopy.
Given the inherent limitations of CSLM, a definitive distinc-
tion of melanoma from an atypical nevus should not be
expected solely based on confocal images. Those images,
however, may help guide the clinical suspicion of an atypical
pigmented lesion and significantly improve upon the diagnostic
accuracy currently achieved with dermoscopy in the distinction
of melanoma from nevi, pigmented basal cell carcinoma
(Charles et al, 2002), or pigmented keratoses, thus avoiding
many currently unnecessary biopsies whereas maintaining ex-
cellent sensitivity for melanoma. It is important to point out that
whereas a skin biopsy is an ‘‘easy’’ procedure to perform, the
associated cost, morbidity, and scarring, especially for facial
lesions, are not trivial from the patient’s perspective.
While findings by CSLM may impact a dermatologist’s
decision to observe or excise a suspicious pigmented le-
sion, much of its bedside value lies in its potential to guide a
clinician to find the most informative sites within a lesion for
tissue sampling to allow for a clear diagnosis and margin
assessment. A number of studies have already documented
the feasibility of this approach (Busam et al, 2001a, b; Cur-
iel-Lewandrowski et al, 2004). Large atypical pigmented le-
sions suspicious for lentigo maligna that are not amenable
to excisional biopsies (e.g., location on the face near the
eyelid) are prone to sampling errors when a partial biopsy is
performed. CSLM provides a clear advantage in this regard
by allowing the clinician to scan the entire surface of the
lesion for an abnormal melanocytic proliferation. If an area
suspicious for in situ melanoma is found using CSLM, a
biopsy taken from that site will more likely yield a definitive
diagnosis than a random biopsy. The same is true for po-
tential sampling errors that may occur in melanomas arising
in precursor nevi. Sampling errors are not only an issue for
dermatologists but also for pathologists. Most biopsy spec-
imens undergo very limited sectioning prior to histologic
evaluation, thus permitting small foci of melanoma to be
undetected. Here too, CSLM may be utilized, before sec-
tioning to scan the entire lesion, and then guide histologic
sectioning or obtain additional sections, if there is no good
correlation between findings obtained by CSLM and initial
conventional histology.
Improved diagnostic accuracy by CSLM is also relevant for
the presurgical mapping of melanoma margins. Assessment
of margins of clinically amelanotic melanomas or lentigo ma-
lignas arising in a background of solar lentigines is very dif-
ficult. In these settings, CSLM may provide a much improved
first approximation of the peripheral borders between the
tumor and normal skin (Busam et al, 2001a, b), especially if the
histology of the tumor is already known from a prior biopsy.
Confocal imaging may also play a role in clinical assessment
of persistent and locally recurrent in situ melanomas under-
going topical therapy (Curiel-Lewandrowski et al, 2004).
In summary, the future potential of in vivo confocal
microscopy to aid dermatologists and dermatopathol-
ogists interested in improving the diagnosis of melanoma
looks bright. But instrumentation advances and additional
clinical research must occur before these technologies
can be applied in routine clinical practice. The work
presented by Pellacani et al. in this issue of the Journal
of Investigative Dermatology (Pellacani et al, 2005) is
important because it distinguishes solid criteria for the
diagnosis of melanoma (extensive pagetoid spread of
atypical melanocytes) from ‘‘soft’’ criteria (epidermal disar-
ray, bright granular refractile particles; Langley et al, 2001).
Although not a novel concept, the work of the authors
reminds us that several histomorphologic features associ-
ated with melanoma, such as pagetoid melanocytosis,
are per se not diagnostic, but need to be judged in context
with other findings. The integration of information from
various sources (clinical, dermoscopic, confocal, and con-
ventional histologic findings, and at times also immuno-
histochemical or molecular data) is the best guarantee for
an accurate diagnosis.
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